IRAK2 c.287_288inv ;(p.A96E)

Variant ID: 3-10242062-CT-AG

NM_001570.3(IRAK2):c.287_288inv;(p.A96E)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Different Mechanisms of Action of Regorafenib and Lenvatinib on Toll-Like Receptor-Signaling Pathways in Human Hepatoma Cell Lines.

International Journal Of Molecular Sciences
Sasaki, Reina R; Kanda, Tatsuo T; Fujisawa, Mariko M; Matsumoto, Naoki N; Masuzaki, Ryota R; Ogawa, Masahiro M; Matsuoka, Shunichi S; Kuroda, Kazumichi K; Moriyama, Mitsuhiko M
Publication Date: 2020-05-09

Variant appearance in text: IRAK2: A96E
PubMed Link: 32397371
Variant Present in the following documents:
  • Main text
View BVdb publication page